Pemetrexed disodium is an investigational, novel, multitargeted antifolate with inhibitory activity against multiple enzymes involved in non-small-cell lung cancer (NSCLC), mesothelioma, and breast, pancreas, colorectal, gastric, cervical, and head and neck cancers, said lead investigator Paul Bunn, Jr., MD, University of Colorado Health Sciences Center, Denver
Charoenkwan P, Tantiworawit A (2022) Treatment strategies for haemoglobin E thalassaemia
These findings are consistent with recent untargeted metabolomics studies revealing reduced glucuronide-conjugated steroids and bile acids and increased levels of several circulating metabolites in healthy individuals carrying a complete UGT2B17 gene deletion and in UGT2B17-deficient cancer patients
PMID: 30293647 An Open Resource for Non-human Primate Imaging
Step 2: Clean the workspace Use a clean, flat surface
Presented for research literature review only Scott RB et al